Myeloma Paper of the Day, July 14th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Small pre-clinical study suggests that microbiota-derived short-chain fatty acids may boost anti-tumoral Natural Killer cell activity in a model of multiple myeloma.”
Source: Robert Orlowski/X
Microbiota-Derived Short-Chain Fatty Acids Boost Antitumoral Natural Killer Cell Activity
Authors: Marina Pérez, Berta Buey, Pilar Corral, David Giraldos, Eva Latorre
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
